OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The landscape of genetic alterations in ameloblastomas relates to clinical features
Sibel Elif Gültekin, Reem Aziz, Carina Heydt, et al.
Virchows Archiv (2018) Vol. 472, Iss. 5, pp. 807-814
Open Access | Times Cited: 70
Sibel Elif Gültekin, Reem Aziz, Carina Heydt, et al.
Virchows Archiv (2018) Vol. 472, Iss. 5, pp. 807-814
Open Access | Times Cited: 70
Showing 1-25 of 70 citing articles:
Overcoming EGFRG724S-mediated osimertinib resistance through unique binding characteristics of second-generation EGFR inhibitors
Jana Fassunke, Fabienne Müller, Marina Keul, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 127
Jana Fassunke, Fabienne Müller, Marina Keul, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 127
Ameloblastoma: An Updated Narrative Review of an Enigmatic Tumor
Suhani Ghai
Cureus (2022)
Open Access | Times Cited: 57
Suhani Ghai
Cureus (2022)
Open Access | Times Cited: 57
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F
Senthil Damodaran, Fengmin Zhao, Dustin A. Deming, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 14, pp. 1552-1561
Open Access | Times Cited: 50
Senthil Damodaran, Fengmin Zhao, Dustin A. Deming, et al.
Journal of Clinical Oncology (2022) Vol. 40, Iss. 14, pp. 1552-1561
Open Access | Times Cited: 50
Clinicoradiologic features of ameloblastomas: A single‐centre study of 155 cases
Chané Smit, Liam Robinson, Jason Ker‐Fox, et al.
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 2, pp. 133-141
Open Access | Times Cited: 8
Chané Smit, Liam Robinson, Jason Ker‐Fox, et al.
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 2, pp. 133-141
Open Access | Times Cited: 8
Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence
Hévila de Figueiredo Pires, Glória Maria de França, Hannah Gil de Farias Morais, et al.
Head and Neck Pathology (2025) Vol. 19, Iss. 1
Closed Access | Times Cited: 1
Hévila de Figueiredo Pires, Glória Maria de França, Hannah Gil de Farias Morais, et al.
Head and Neck Pathology (2025) Vol. 19, Iss. 1
Closed Access | Times Cited: 1
Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation
Gustavo dos Santos Fernandes, Daniel M. Girardi, João Paulo Giacomini Bernardes, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 69
Gustavo dos Santos Fernandes, Daniel M. Girardi, João Paulo Giacomini Bernardes, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 69
Ameloblastoma: A succinct review of the classification, genetic understanding and novel molecular targeted therapies
Hongyi Adrian Shi, Chee Wee Ng, Chong Teck Kwa, et al.
The Surgeon (2020) Vol. 19, Iss. 4, pp. 238-243
Closed Access | Times Cited: 57
Hongyi Adrian Shi, Chee Wee Ng, Chong Teck Kwa, et al.
The Surgeon (2020) Vol. 19, Iss. 4, pp. 238-243
Closed Access | Times Cited: 57
The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors
Letícia Martins Guimarães, Bruna Pizziolo Coura, Ricardo Santiago Gomez, et al.
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 45
Letícia Martins Guimarães, Bruna Pizziolo Coura, Ricardo Santiago Gomez, et al.
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 45
Advancements in MAPK signaling pathways and MAPK ‐targeted therapies for ameloblastoma: A review
Zhu You, Shao‐Peng Liu, Jing Du, et al.
Journal of Oral Pathology and Medicine (2018) Vol. 48, Iss. 3, pp. 201-205
Closed Access | Times Cited: 50
Zhu You, Shao‐Peng Liu, Jing Du, et al.
Journal of Oral Pathology and Medicine (2018) Vol. 48, Iss. 3, pp. 201-205
Closed Access | Times Cited: 50
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
Rogelio Gónzalez‐Gónzalez, Sandra López‐Verdín, Jesús Lavalle‐Carrasco, et al.
World Journal of Clinical Oncology (2019) Vol. 11, Iss. 1, pp. 31-42
Open Access | Times Cited: 48
Rogelio Gónzalez‐Gónzalez, Sandra López‐Verdín, Jesús Lavalle‐Carrasco, et al.
World Journal of Clinical Oncology (2019) Vol. 11, Iss. 1, pp. 31-42
Open Access | Times Cited: 48
Adenoid ameloblastoma harbors beta-catenin mutations
Victor Coutinho Bastos, Bruna Pizziolo Coura, Letícia Martins Guimarães, et al.
Modern Pathology (2022) Vol. 35, Iss. 11, pp. 1562-1569
Open Access | Times Cited: 25
Victor Coutinho Bastos, Bruna Pizziolo Coura, Letícia Martins Guimarães, et al.
Modern Pathology (2022) Vol. 35, Iss. 11, pp. 1562-1569
Open Access | Times Cited: 25
Molecular pathogenesis of ameloblastoma
Constanza Celia Nieto Marín, Janine Kirby, Keith D. Hunter
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 5, pp. 277-293
Closed Access | Times Cited: 5
Constanza Celia Nieto Marín, Janine Kirby, Keith D. Hunter
Journal of Oral Pathology and Medicine (2024) Vol. 53, Iss. 5, pp. 277-293
Closed Access | Times Cited: 5
Durable disease regression with copanlisib treatment in PI3K-mutated metastasizing ameloblastoma: A case report
Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, et al.
Rare Tumors (2025) Vol. 17
Open Access
Meghan M Lynch, Pedro Hermida-Viveiros, Sean Stencel, et al.
Rare Tumors (2025) Vol. 17
Open Access
From Pathogenesis to Precision Medicine: Transformative Advances in Research and Treatment of Ameloblastoma
Zhao Zhang, Gan Xiong, Cheng Wang, et al.
Cancer Letters (2025), pp. 217448-217448
Closed Access
Zhao Zhang, Gan Xiong, Cheng Wang, et al.
Cancer Letters (2025), pp. 217448-217448
Closed Access
Novel Histologic Features in Ameloblastoma With RAS Q61R Mutation
Ivan J. Stojanov, Anna M. Trzcinska, Mohammed Qaisi, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Ivan J. Stojanov, Anna M. Trzcinska, Mohammed Qaisi, et al.
The American Journal of Surgical Pathology (2025)
Closed Access
Exploring treatment complexity in maxillary ameloblastoma: A case study on the efficacy of radiotherapy with transcriptomic and literature insights
Léa Marxgut, P. Fourneret, Waïsse Waïssi
Cancer/Radiothérapie (2025) Vol. 29, Iss. 1, pp. 104591-104591
Open Access
Léa Marxgut, P. Fourneret, Waïsse Waïssi
Cancer/Radiothérapie (2025) Vol. 29, Iss. 1, pp. 104591-104591
Open Access
Unveiling Radiographic Features and Radio-pathological Correlations of Ameloblastoma: A Retrospective Study
Rashi Mandlik, Ajay Parihar, Prashanthi Reddy, et al.
Archives of Medicine and Health Sciences (2025)
Open Access
Rashi Mandlik, Ajay Parihar, Prashanthi Reddy, et al.
Archives of Medicine and Health Sciences (2025)
Open Access
Odontogenic Tumors in Sweden, Norway, Finland, and Denmark: A Multicenter Study
Tine M. Søland, Anna Ljunggren, A. Abuharb, et al.
Journal of Oral Pathology and Medicine (2025)
Closed Access
Tine M. Søland, Anna Ljunggren, A. Abuharb, et al.
Journal of Oral Pathology and Medicine (2025)
Closed Access
Ameloblastic Carcinoma: A 40-Year Scoping Review of the Literature
Maria Giulia Cristofaro, Ida Barca, Angelo Ruggero Sottile, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 261-261
Open Access
Maria Giulia Cristofaro, Ida Barca, Angelo Ruggero Sottile, et al.
Current Issues in Molecular Biology (2025) Vol. 47, Iss. 4, pp. 261-261
Open Access
High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial‐mesenchymal transition
Kyu‐Young Oh, Sung‐Dae Cho, Hye‐Jung Yoon, et al.
Journal of Oral Pathology and Medicine (2019) Vol. 48, Iss. 5, pp. 413-420
Closed Access | Times Cited: 34
Kyu‐Young Oh, Sung‐Dae Cho, Hye‐Jung Yoon, et al.
Journal of Oral Pathology and Medicine (2019) Vol. 48, Iss. 5, pp. 413-420
Closed Access | Times Cited: 34
Update on Odontogenic Tumors: Proceedings of the North American Head and Neck Pathology Society
Elizabeth Ann Bilodeau, Raja R. Seethala
Head and Neck Pathology (2019) Vol. 13, Iss. 3, pp. 457-465
Open Access | Times Cited: 31
Elizabeth Ann Bilodeau, Raja R. Seethala
Head and Neck Pathology (2019) Vol. 13, Iss. 3, pp. 457-465
Open Access | Times Cited: 31
Discovery of novel molecular characteristics and cellular biological properties in ameloblastoma
Sayuri Kondo, Akinobu Ota, Takayuki Ono, et al.
Cancer Medicine (2020) Vol. 9, Iss. 8, pp. 2904-2917
Open Access | Times Cited: 31
Sayuri Kondo, Akinobu Ota, Takayuki Ono, et al.
Cancer Medicine (2020) Vol. 9, Iss. 8, pp. 2904-2917
Open Access | Times Cited: 31
BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis
Mohd Nazzary Mamat Yusof, Ewe Seng Ch’ng, Nawal Radhiah Abdul Rahman
Cancers (2022) Vol. 14, Iss. 22, pp. 5593-5593
Open Access | Times Cited: 16
Mohd Nazzary Mamat Yusof, Ewe Seng Ch’ng, Nawal Radhiah Abdul Rahman
Cancers (2022) Vol. 14, Iss. 22, pp. 5593-5593
Open Access | Times Cited: 16
Association of MDM2 Overexpression in Ameloblastomas with MDM2 Amplification and BRAFV600E Expression
Konstantinos I. Tosios, Eleni‐Marina Kalogirou, Ioannis G. Koutlas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2238-2238
Open Access | Times Cited: 3
Konstantinos I. Tosios, Eleni‐Marina Kalogirou, Ioannis G. Koutlas
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2238-2238
Open Access | Times Cited: 3
Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas
Alan Motta do Canto, Barbara Michaela Reis da Silva Marcelino, Juliana Lucena Schussel, et al.
Clinical Oral Investigations (2018) Vol. 23, Iss. 2, pp. 779-784
Closed Access | Times Cited: 30
Alan Motta do Canto, Barbara Michaela Reis da Silva Marcelino, Juliana Lucena Schussel, et al.
Clinical Oral Investigations (2018) Vol. 23, Iss. 2, pp. 779-784
Closed Access | Times Cited: 30
